SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.

Yumi Takiyama, Bessho R, Maeda Manami, Kuralay Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Atsuko Abiko, Yuichi Makino, Masakazu Haneda

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationSGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.
PublisherAmerican Diabetes Association Inc.
PagesA136-A136
Publication statusPublished - Jun 2014

Cite this

Takiyama, Y., R, B., Manami, M., Atageldiyeva, K., Yanagimachi, T., Honjo, J., ... Haneda, M. (2014). SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. In SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. (pp. A136-A136). American Diabetes Association Inc..

SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. / Takiyama, Yumi; R, Bessho; Manami, Maeda; Atageldiyeva, Kuralay; Yanagimachi, Tsuyoshi ; Honjo, Jun; Fujita, Yukihiro; Abiko, Atsuko; Makino, Yuichi ; Haneda, Masakazu.

SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.. American Diabetes Association Inc., 2014. p. A136-A136.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Takiyama, Y, R, B, Manami, M, Atageldiyeva, K, Yanagimachi, T, Honjo, J, Fujita, Y, Abiko, A, Makino, Y & Haneda, M 2014, SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. in SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.. American Diabetes Association Inc., pp. A136-A136.
Takiyama Y, R B, Manami M, Atageldiyeva K, Yanagimachi T, Honjo J et al. SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. In SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.. American Diabetes Association Inc. 2014. p. A136-A136
Takiyama, Yumi ; R, Bessho ; Manami, Maeda ; Atageldiyeva, Kuralay ; Yanagimachi, Tsuyoshi ; Honjo, Jun ; Fujita, Yukihiro ; Abiko, Atsuko ; Makino, Yuichi ; Haneda, Masakazu. / SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.. American Diabetes Association Inc., 2014. pp. A136-A136
@inproceedings{6548a32885094cdca0a8f779588498d1,
title = "SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.",
author = "Yumi Takiyama and Bessho R and Maeda Manami and Kuralay Atageldiyeva and Tsuyoshi Yanagimachi and Jun Honjo and Yukihiro Fujita and Atsuko Abiko and Yuichi Makino and Masakazu Haneda",
year = "2014",
month = "6",
language = "English",
pages = "A136--A136",
booktitle = "SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.",
publisher = "American Diabetes Association Inc.",
address = "United States",

}

TY - GEN

T1 - SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.

AU - Takiyama, Yumi

AU - R, Bessho

AU - Manami, Maeda

AU - Atageldiyeva, Kuralay

AU - Yanagimachi, Tsuyoshi

AU - Honjo, Jun

AU - Fujita, Yukihiro

AU - Abiko, Atsuko

AU - Makino, Yuichi

AU - Haneda, Masakazu

PY - 2014/6

Y1 - 2014/6

M3 - Conference contribution

SP - A136-A136

BT - SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes.

PB - American Diabetes Association Inc.

ER -